Pharmacokinetics in Patients with Impaired Hepatic Function: Study Design, Data Analysis, and Impact on Dosing and Labeling
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 30, 2003
January 31, 2025
578ee829-2b5f-40bd-8dca-59c140a08ef9
Related Documents
Good Pharmacovigilance Practices and Pharmacoepidemiologic Assessment: Guidance for Industry
Guidance DocumentMarch 24, 2005Center for Drug Evaluation and Research
Exposure-Response Relationships — Study Design, Data Analysis, and Regulatory Applications
Guidance DocumentMay 5, 2003Center for Drug Evaluation and Research
Nasal Spray and Inhalation Solution, Suspension, and Spray Drug Products--Chemistry, Manufacturing, and Controls Documentation: Guidance for Industry
Guidance DocumentJuly 5, 2002Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.